PRA5 HEALTH CARE RESOURCES UTILIZATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE  by Lachaine, J & Bradley-Kennedy, C
188 Abstracts
PAR5
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Ingelheim Canada Ltd, Burlington, QC, Canada
Chronic Obstructive Pulmonary Disease (COPD) is
among the leading cause of death in North America.
Despite its high prevalence, morbidity and mortality, little
is known about its impact on health care resources 
utilization.
OBJECTIVES: To deﬁne the patient proﬁle for COPD
and quantify health care resource utilization of patients
with a diagnosis of COPD in term of hospitalization,
visits to the emergency department, use of medical 
services, and medications use.
METHODS: The study was conducted using data from
the Quebec Provincial Drug Plan (QPDP) databases.
From a random sample representing 10% of the popula-
tion covered by the QPDP, two different cohorts were
extracted from the databases—one comprising subjects
diagnosed with COPD and a comparison group, matched
for sex and age group, of subjects without COPD.
RESULTS: The proportion of COPD in the population
covered by the QPDP drug plan was 4.8%, with a higher
proportion among men than among women. On average
the cost difference between COPD and non-COPD was
$8,897 ($14,728 vs. $5,831) over a three-year period or
$2,966 per patient per year. In both groups costs of health
care resource increase with age, but cost in the COPD
group were higher than in the non-COPD group for each
age category. COPD patients had more days of hos-
pitalization, more visits to the emergency, more hospital
outpatient clinics and more physician visits in private
ofﬁces. In addition, the consumption of medical services
and pharmaceutical services was higher in the COPD
group than in the non-COPD group.
CONCLUSION: COPD is a frequent disease affecting a
large proportion of the elderly population and represent
a signiﬁcant burden to the health care system. Patients
with COPD use a higher quantity of health care resources
than those who are not diagnosed with COPD. This
translates into higher health care costs.
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ESTABLISHING THE RELIABILITY OF 
EVIDENCE FOR THE SIGNIFICANT IMPACT OF
ALLERGIC RHINITIS ON HEALTH RELATED
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OBJECTIVES: To describe the similarities of the magni-
tude of lost work performance related to allergic rhinitis
in multiple industries.
METHODS: 14,000 employees from 10 western U.S.
employers in four industries (local government, public
schools, gaming/casino, and healthcare/medical) were
asked to participate in a cross-sectional study of allergic
rhinitis. An anonymous, self-administered questionnaire
was distributed at the worksite and returned to a third
party to assure conﬁdentiality. The questionnaire
included items assessing allergy severity, symptoma-
tology, medication use, health service utilization, self-
management knowledge and practices, sociodemograph-
ics and lost work performance (due to full and partial
missed days and presenteeism). Response rates by 
industry ranged from 30% to 85% with 2,493 employ-
ees reporting that they currently had allergies.
RESULTS: The average age of responders ranged from 39
to 46. 92% of responders from the healthcare/medical
industry were female compared with 82% from public
schools, 66% from gaming/casinos and 63% from local
government. Approximately 75% of employees from
local government, public schools and gaming/casinos
reported moderate to severe allergies versus 60% in 
the healthcare/medical industry. On average, 25–33% of
employees across industries reported use of non-sedating
antihistamines. Despite demographic differences, there
were consistencies regarding lost work performance
across all industries ranging from 16.4 hours lost in
public schools to 18.1 in gaming/casinos. Presenteeism
accounted for the majority (75%) of these hours across
industries.
CONCLUSIONS: The replication of lost work per-
formance ﬁndings provides strong evidence of the sub-
stantial disease burden of allergic rhinitis of a diversity 
of workers across different occupational categories and
industries. This study supports estimates that lost work
performance from allergic rhinitis is four to ﬁve times
greater than direct medical expenditures and must be
included when measuring total health related costs to
employers. Allergic rhinitis, like migraines, presents a sig-
niﬁcant opportunity for employers to reduce health-
related costs via targeted interventions.
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OBJECTIVES: Chronic obstructive pulmonary disease
(COPD) is a signiﬁcant public health problem resulting 
in substantial societal burden. The main objective of this
study was to estimate direct medical costs attributable to
COPD.
METHODS: Data from the Household Component of
1996 Medical Expenditures Panel Survey (MEPS), a
nationally representative sample of the non-
